Allos Therapeutics (ALTH) Posts Q1 EPS Loss $0.14
Tweet Send to a Friend
Allos Therapeutics (NASDAQ: ALTH) reported Q1 EPS of ($0.14), $0.01 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
